[Leslie Carol Botha: It is about time that the fraud and deception on medical consumers who believe in their government and the medical industry comes to a halt. The cost and damage to people’s lives is astronomical. If you want to know what pharma reps are saying about their own industry go to Cafe Pharma
Here’s just one example:
Idiot. Its the same reason all other drugs are sold. Profit. “Cure” breast cancer and you can charge what its WORTH..think total (not just drug) costs for a terminal breast cancer patient. I have no idea what that number is but SWAG it at $500k.
“Cure” it and you can charge $400k, save the “system” $100k and more importantly save the individual’s life. Whats that WORTH?
More drug companies to pay billions for fraud, join the “dishonor roll” after Abbott settlement
Erika Kelton, Contributor
May 12, 2012
With Abbott’s $1.5 billion settlement of a whistleblower-initiated case this week, Abbott joins an infamous list of pharma companies that have paid more than one billion dollars to the federal government for illegal marketing practices, including promoting prescription drugs for uses not approved by the FDA, paying financial inducements to increase sales and engaging in practices that pose grave danger to patients’ health and lives.
This dishonor roll includes pharma giants Pfizer, which paid $2.3 billion to the government in 2009, and Eli Lilly, which settled civil and criminal charges earlier in 2009 for $1.4 billion.
Soon there will be more additions to pharma’s billion-dollar-plus club: GlaxoSmithKline announced last November that it had reached an agreement in principle to pay $3 billion this year to resolve multiple government investigations into its sales and marketing practices. And Johnson & Johnson (J&J ) reportedly is in negotiations with the government to pay more than $1 billion to settle civil charges for the off-label marketing of Risperdal and Invega.
Meanwhile, Amgen said last Octoberthat it had reached an agreement in principle to pay $780 million to settle litigation involving state Medicaid investigations and 10 “qui tam” (whistleblower) lawsuits involving illegal marketing practices.
Despite the prosecutions, huge fines and bad publicity, too many pharma companies have failed to change their ways. Billion-dollar settlements are to some just the cost of doing business. At my firm, we continue to see a steady stream of whistleblowers with powerful evidence of pharma wrongdoing – be it illegal promotion of prescription drugs; financial inducements to doctors and pharmacists to prescribe or sell certain prescription drugs; manufacturing practices that contaminate drugs; and the use of phony science to support FDA approval or shady marketing, to name just a few.